Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis

dc.contributorUniversidade de São Paulo (USP)
dc.contributorPontificia Univ Catolica Rio Grande do Sul
dc.contributorUniversidade Federal de Minas Gerais (UFMG)
dc.contributorUniv Jose Rosario Vellano
dc.contributorUniv Fed Estado Rio de Janeiro
dc.contributorHosp Restauracao
dc.contributorClin Goncalves Dias
dc.contributorUniversidade Estadual de Campinas (UNICAMP)
dc.contributorClin Privada
dc.contributorHosp Sao Rafael
dc.contributorUniversidade Federal Fluminense (UFF)
dc.contributorFundacac Ctr Integrado Apoio Portador Deficiencia
dc.contributorUniversidade de Brasília (UnB)
dc.contributorUniv Catolica Brasilia
dc.contributorSanta Casa Misericordia Londrina
dc.contributorUniversidade Federal de Goiás (UFG)
dc.contributorClin Neurol & Endocrinol
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorInst Neurol Curitiba
dc.contributorUniv Regiao Joinville
dc.contributorUniv Fed Amazonas
dc.contributorPontificia Univ Catolica Sao Paulo
dc.contributorSenne Liquor Diagnost
dc.contributorHosp Cruz Azul
dc.contributorFac Sao Leopoldo Mandic
dc.contributorHosp Israelita Albert Einstein
dc.contributorUniversidade Federal de Uberlândia (UFU)
dc.contributorHosp Base Dist Fed
dc.contributorImperial Hosp Caridade
dc.contributorEscola Bahiana Med & Saude Publ
dc.date.accessioned2018-11-26T22:40:49Z
dc.date.available2018-11-26T22:40:49Z
dc.date.created2018-11-26T22:40:49Z
dc.date.issued2018-08-01
dc.identifierArquivos De Neuro-psiquiatria. Sao Paulo Sp: Assoc Arquivos Neuro- Psiquiatria, v. 76, n. 8, p. 539-554, 2018.
dc.identifier0004-282X
dc.identifierhttp://hdl.handle.net/11449/164827
dc.identifier10.1590/0004-282X20180078
dc.identifierS0004-282X2018000800539
dc.identifierWOS:000444425800009
dc.identifierS0004-282X2018000800539.pdf
dc.description.abstractThe expanding therapeutic arsenal in multiple sclerosis (MS) has allowed for more effective and personalized treatment, but the choice and management of disease-modifying therapies (DMTs) is becoming increasingly complex. In this context, experts from the Brazilian Committee on Treatment and Research in Multiple Sclerosis and the Neuroimmunology Scientific Department of the Brazilian Academy of Neurology have convened to establish this Brazilian Consensus for the Treatment of MS, based on their understanding that neurologists should be able to prescribe MS DMTs according to what is better for each patient, based on up-to-date evidence and practice. We herein propose practical recommendations for the treatment of MS, with the main focus on the choice and management of DMTs, as well as present a review of the scientific rationale supporting therapeutic strategies in MS.
dc.languageeng
dc.publisherAssoc Arquivos Neuro- Psiquiatria
dc.relationArquivos De Neuro-psiquiatria
dc.rightsAcesso aberto
dc.sourceWeb of Science
dc.subjectmultiple sclerosis
dc.subjectdrug therapy
dc.subjectconsensus
dc.titleBrazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución